FDA Inspection
GE Healthcare Inc.GE Healthcare Inc. – FDA Inspection, Mar 8, 2024
Record Details
This FDA Inspection record concerns GE Healthcare Inc., with an inspection on March 8, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ab3eaa59-c633-46ea-8be0-e091bbd9031c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1232232
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of GE Healthcare Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 2, 2023 | Not classified | Chicago District Office | |
| January 24, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2017 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| March 5, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for GE Healthcare Inc.
- FDA Inspection 1287530 - 2025-09-19
- FDA Inspection 1221712 - 2023-10-02
- FDA Inspection 1117219 - 2020-01-24
- FDA Inspection 1026911 - 2017-09-06
- FDA Inspection 916324 - 2015-03-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.